iOnctura expands Advisory Board
September 27, 2022 02:00 ET
|
iOnctura
Geneva, Switzerland, 27 September 2022 -- iOnctura SA, a clinical-stage biotech developing selective cancer therapies against targets that play critical roles in multiple tumor survival pathways,...
3B Future Health Fund announces new investment in iOnctura
July 14, 2020 03:00 ET
|
Helsinn Healthcare S.A.
3B Future Health Fund announces new investment in iOnctura MONACO, PRINCIPALITY OF MONACO, July 14, 2020: 3B Future Health Fund, previously known as Helsinn Investment Fund S.A., SICAR, today...